gadolinium ethoxybenzyl DTPA
(SLYTULCOCGSBBJ-UHFFFAOYSA-I)
Structure
- SMILES
- CCOc1ccc(cc1)CC(N(CC(=O)[O-])CC(=O)[O-])CN(CC(=O)[O-])CCN(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Gd+3]
- Molecular Formula:
- C23H28GdN3Na2O11
- Molecular Weight:
- 725.711
- Log P:
- -7.3481
- Hydrogen Bond Acceptor:
- 14
- Hydrogen Bond Donor:
- 0
- TPSA:
- 219.6
- CAS Number(s):
- 135326-22-6
Synonym(s)
1.
gadolinium ethoxybenzyl DTPA
2.
Eovist
3.
Gd-EOB-DTPA
4.
Primovist
5.
disodium gadoxetate
6.
gadolinium (4S)-4-(4-ethoxybenzyl)-3,6,9-tris(carboxylatomethyl)-3,6,9-triazaundecanoic acid disodium salt
7.
gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid
8.
gadoxetate disodium
9.
gadoxetic acid
10.
gadoxetic acid disodium
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Urticaria | FAERS: 28 | US FAERS | |
| 2 | Nausea | FAERS: 27 | US FAERS | |
| 3 | Vomiting | FAERS: 14 | US FAERS | |
| 4 | Pruritus | FAERS: 13 | US FAERS | |
| 5 | Chest discomfort | FAERS: 7 | US FAERS | |
| 6 | Dizziness | FAERS: 6 | US FAERS | |
| 7 | No adverse event | FAERS: 5 | US FAERS | |
| 8 | Adverse event | FAERS: 4 | US FAERS | |
| 9 | Erythema | FAERS: 4 | US FAERS | |
| 10 | Throat irritation | FAERS: 4 | US FAERS | |
| 11 | Anxiety | FAERS: 3 | US FAERS | |
| 12 | Burning sensation | FAERS: 3 | US FAERS | |
| 13 | Drug ineffective | FAERS: 3 | US FAERS | |
| 14 | Hypersensitivity | FAERS: 3 | US FAERS | |
| 15 | Malaise | FAERS: 3 | US FAERS | |
| 16 | Nerve injury | FAERS: 3 | US FAERS | |
| 17 | Oral pruritus | FAERS: 3 | US FAERS | |
| 18 | Poor peripheral circulation | FAERS: 3 | US FAERS | |
| 19 | Respiratory distress | FAERS: 3 | US FAERS | |
| 20 | Vasospasm | FAERS: 3 | US FAERS | |
| 21 | Abdominal discomfort | FAERS: 2 | US FAERS | |
| 22 | Chest Pain | FAERS: 2 | US FAERS | |
| 23 | Choking sensation | FAERS: 2 | US FAERS | |
| 24 | Disorientation | FAERS: 2 | US FAERS | |
| 25 | Headache | FAERS: 2 | US FAERS | |
| 26 | Hyperventilation | FAERS: 2 | US FAERS | |
| 27 | Injection site pruritus | FAERS: 2 | US FAERS | |
| 28 | Inspiratory capacity decreased | FAERS: 2 | US FAERS | |
| 29 | Palpitations | FAERS: 2 | US FAERS | |
| 30 | Tremor | FAERS: 2 | US FAERS | |
| 31 | Anaphylactoid Reaction | FAERS: 1 | US FAERS | |
| 32 | Aphonia | FAERS: 1 | US FAERS | |
| 33 | Asthenia | FAERS: 1 | US FAERS | |
| 34 | Chills | FAERS: 1 | US FAERS | |
| 35 | Dysgeusia | FAERS: 1 | US FAERS | |
| 36 | Dysphonia | FAERS: 1 | US FAERS | |
| 37 | Feeling abnormal | FAERS: 1 | US FAERS | |
| 38 | Feeling jittery | FAERS: 1 | US FAERS | |
| 39 | Flushing | FAERS: 1 | US FAERS | |
| 40 | Head discomfort | FAERS: 1 | US FAERS | |
| 41 | Incoherent | FAERS: 1 | US FAERS | |
| 42 | Injection Site Reaction | FAERS: 1 | US FAERS | |
| 43 | Injection site erythema | FAERS: 1 | US FAERS | |
| 44 | Lip swelling | FAERS: 1 | US FAERS | |
| 45 | Oropharyngeal pain | FAERS: 1 | US FAERS | |
| 46 | Pallor | FAERS: 1 | US FAERS | |
| 47 | Rash erythematous | FAERS: 1 | US FAERS | |
| 48 | Respiratory arrest | FAERS: 1 | US FAERS | |
| 49 | Respiratory tract congestion | FAERS: 1 | US FAERS | |
| 50 | Sneezing | FAERS: 1 | US FAERS | |
| 51 | Tension Headache | FAERS: 1 | US FAERS | |
| 52 | Tension | FAERS: 1 | US FAERS | |
| 53 | Unresponsive to stimuli | FAERS: 1 | US FAERS | |
| 54 | Urinary Incontinence | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120238
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.